ANI Pharmaceuticals
ANIP
#5263
Rank
HK$12.24 B
Marketcap
HK$538.93
Share price
-0.55%
Change (1 day)
-13.84%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): HK$40.55

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$40.61. In 2025 the company made an earnings per share (EPS) of HK$27.44 an increase over its 2024 EPS that were of -HK$8.78.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$40.5547.79%
2025HK$27.44-412.5%
2024-HK$8.78
2022-HK$23.83-6.46%
2021-HK$25.4872.87%
2020-HK$14.74-476%
2019HK$3.92-62.12%
2018HK$10.35
2015HK$10.50-47.66%
2014HK$20.07-142.11%
2013-HK$47.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.16 1.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-86.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
HK$60.83 49.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$28.46-29.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
-HK$19.75-148.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.10-183.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$3.53-91.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
HK$11.99-70.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-HK$198.17-588.03%๐Ÿ‡บ๐Ÿ‡ธ USA